Browsing: drugs

Here’s a look into Silicon Valley’s ‘executive psychedelic slumber parties’ that cost over ,000

Here’s a look into Silicon Valley’s ‘executive psychedelic slumber parties’ that cost over $3,000

By Press Room18 February 2025

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…

Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive

By Press Room15 February 2025

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By Press Room6 February 2025

Hannah Richardson, 24, undergoes a brain scan as part of the Primary Prevention Trial for Alzheimer’s disease led by Washington…

The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits

The aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits

By Press Room4 February 2025

Nearly half of survey respondents (48%) incorrectly said that the benefits of taking low-dose aspirin daily to lower one’s odds…

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By Press Room3 February 2025

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By Press Room22 January 2025

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…

Mark Cuban’s 1K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big

Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big

By Press Room8 January 2025

“Even though health insurance costs are the second-largest line item after payroll, CEOs don’t really understand it or know anything…

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1

By Press Room3 January 2025

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use…

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By Press Room20 December 2024

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By Press Room5 December 2024

GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes…